NCT07113249

Brief Summary

Rhythmic Gymnastics is an Olympic discipline featuring individual or team competition. Regardless of the type of competition, athletes undergo rigorous training focused on enhancing their coordination, joint range of motion, and jump height. Each rhythmic gymnast voluntarily underwent testing at their own gym after reading and signing the informed consent document. During the first session, general information was collected on all participants (age, weight, and height), followed by an assessment of athletic performance and joint mobility parameters. For the jump performance parameters, the Counter Movement Jump test (CMJ) was used through an optical detecting system. An inertial sensor was used to measure joint mobility, while a pressure platform was used to measure ankle stability, using a single-leg jump protocol. Subsequently, participants were randomly divided into two groups: an experimental group (EG) and a control group (CG). The EG performed three sets, each lasting 60 seconds, with a 30-second break between sets for two times for week for 3 weeks. During each FR session, a complete sequential movement was always performed, starting from the gastrocnemius muscles and ending with the soleus muscle. At the end of the three weeks, all measurements were repeated.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2025

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2025

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

August 2, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 8, 2025

Completed
Last Updated

August 17, 2025

Status Verified

July 1, 2025

Enrollment Period

2 months

First QC Date

August 2, 2025

Last Update Submit

August 12, 2025

Conditions

Keywords

Rhythmic GymnastsPerformanceInjury Prevention

Outcome Measures

Primary Outcomes (3)

  • Counter Movement Jump (CMJ)

    Initially, the athlete stands upright on a flat surface or force platform, feet shoulder-width apart, hands on hips (to eliminate arm swing). Without a pause, the athlete performs a quick downward movement (countermovement) by bending the knees and hips, then immediately jumps vertically as high as possible. The athlete lands in an upright position on the same spot, trying to absorb the impact with knees slightly bent. Jump height and flight time is recorded using an optical system, Optojump™ system(Microgate, Bolzano, Italy) connected to a personal computer with dedicated software(OptojumpTM Next software). The system consists of two optical bars, a receiver and a transmitter, positioned 1m apart. The bars identify ground contact time(with a precision of 1ms) and then convert non-contact time into cm. Based on recommendations on optimal jump height (20 to 60cm).

    At the beginning of enrollment ( Baseline, T0) and the end of the 3-week treatment (T1)

  • Ankle Dorsiflexion ROM

    Each participant was fitted with an inertial sensor (Beyond Inertial, Motusech, Roma, Itay) in the center of the foot, using an elastic band supplied with the sensor. The starting position was standardized with the subjects sitting on a medical bed with the popliteal cord attached to the edge of the bed, forming a 90° angle. The position of the foot, on the other hand, was placed in a neutral position using a laser level. Subsequently, the dorsal flexion movement was performed.

    At the beginning of enrollment ( Baseline, T0) and the end of the 3-week treatment (T1)

  • Ankle Stability

    Ankle stability was assessed using a functional monopodalic protocol, which involved four jumps on one foot: two per leg, both frontally and laterally. These jumps were performed by stepping over an adjustable obstacle set at 70% of the maximum height reached on a pressure platform (SensorMedica freeMed 40×40, Guidonia Montecelio, Italy). The platform has an active sensory surface of 40×40 cm with a thickness of only 8 mm and a low weight of approximately 4 kg. Inside, there are resistive sensors coated in 24K gold on conductive rubber, with a density of approximately 10,000 sensors/m².The acquisition frequency is high, up to 400 Hz, allowing for detailed dynamic analysis, and the sensors have a life cycle of over 1,000,000 cycles of use

    At the beginning of enrollment ( Baseline, T0) and the end of the 3-week treatment (T1)

Study Arms (2)

Experimental: Foam Rolling (FR)

EXPERIMENTAL

Three sets, each lasting 60 seconds, with a 30-second break between sets for two times for week. During each FR session, a complete sequential movement was always performed, starting from the gastrocnemius muscles and ending with the soleus. A metronome was set to play one complete repetition every 2 seconds to establish the speed of execution.

Other: Foam Rolling (FR)

Control Group (CG)

NO INTERVENTION

Interventions

For the FR, participants were asked to place the roller behind their leg. Three sets, each lasting 60 seconds, with a 30-second break between sets, were performed, for a total of 90 rolls per set.

Experimental: Foam Rolling (FR)

Eligibility Criteria

Age9 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Active participation in competitive training programs (at least 10 hours per week), at least one year of experience in competitions organized by the Italian Gymnastics Federation, and no recent injuries.

You may not qualify if:

  • Presence of current or not fully recovered injuries to the ankle or foot, and irregular participation in training sessions within the four weeks preceding the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Palermo

Palermo, Italy, 90144, Italy

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Experimental Group (EG) and Control Group (CG)
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr.

Study Record Dates

First Submitted

August 2, 2025

First Posted

August 8, 2025

Study Start

May 1, 2025

Primary Completion

June 15, 2025

Study Completion

June 30, 2025

Last Updated

August 17, 2025

Record last verified: 2025-07

Locations